CLOs on the Move

Haemonetics

www.haemonetics.com

 
We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details
Frank Chan
Executive Vice President & Chief Operating Officer Profile
Lisa Lent
Vice President, Associate General Counsel, Chief Compliance Officer Profile

Similar Companies

MicroTransponder Inc.

MicroTransponder has developed the Paired Vagus Nerve Stimulation System (Paired VNS™ System) based on decades of neuroscience research. The Paired VNS™ System is designed to treat several neurological conditions. Our initial focus is upper limb deficits among chronic stroke patients.

BIO-Medical Instruments

BIO-Medical Instruments is a Chantilly, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Outpatient Infusion Systems

Outpatient Infusion Systems is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.

Tech-Med Services

Tech-Med Services is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.